Pine Haven Investment Counsel’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$512K Buy
427
+10
+2% +$10.2K 0.34% 73
2026
Q1
$384K Hold
417
0.28% 80
2025
Q4
$448K Buy
417
+6
+1% +$5.74K 0.32% 74
2025
Q3
$314K Buy
411
+5
+1% +$3.72K 0.23% 89
2025
Q2
$316K Buy
406
+6
+2% +$4.66K 0.25% 82
2025
Q1
$330K Hold
400
0.28% 79
2024
Q4
$309K Hold
400
0.25% 85
2024
Q3
$354K Hold
400
0.29% 81
2024
Q2
$362K Hold
400
0.31% 76
2024
Q1
$311K Hold
400
0.27% 81
2023
Q4
$233K Hold
400
0.22% 91
2023
Q3
$215K Buy
+400
New +$206K 0.22% 91

Other funds holding LLY

Pine Haven Investment Counsel's LLY Position: Q2 2026 in Review

Pine Haven Investment Counsel increased its Eli Lilly (LLY) stake by 2.4% in Q2 2026, buying an estimated $10.2K and bringing the position to 427 shares worth $512K. The position accounts for 0.34% of the portfolio, ranked #73.

Pine Haven Investment Counsel first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. 1,393 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Pine Haven Investment Counsel held 427 shares of Eli Lilly worth $512K as of Q2 2026.
  • Pine Haven Investment Counsel bought 10 Eli Lilly shares in Q2 2026, an estimated $10.2K.
  • Eli Lilly made up 0.34% of Pine Haven Investment Counsel's portfolio in Q2 2026, its #73 holding.
  • Pine Haven Investment Counsel first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • 1,393 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Pine Haven Investment Counsel's 13F filing for Q2 2026, filed 8 Jul 2026.